✦ LIBER ✦

Time to question long-term safety of routine scheduled inhaled β-2-agonist treatment for COPD

✍ Scribed by Douglas C. McCrory

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multivalent approach to the discovery

✍ John R. Jacobsen; Seok Ki Choi; Jesse Combs; Eric J.L. Fournier; Uwe Klein; Juer 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 838 KB

Long-Acting β2-Agonists or Leukotriene R

✍ Nils Ringdal 📂 Article 📅 2003 🏛 Springer International Publishing AG 🌐 English ⚖ 249 KB

PRS28 Adherence to Current Guidelines fo

✍ Asche, C.; Leader, S.; Plauschinat, C.; Raparla, S.; Ye, X.; Yan, M.; Young, D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB